CH277825A - Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen. - Google Patents
Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen.Info
- Publication number
- CH277825A CH277825A CH277825DA CH277825A CH 277825 A CH277825 A CH 277825A CH 277825D A CH277825D A CH 277825DA CH 277825 A CH277825 A CH 277825A
- Authority
- CH
- Switzerland
- Prior art keywords
- preparation
- solutions containing
- injection solutions
- levulose
- containing levulose
- Prior art date
Links
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 title 1
- 229960002737 fructose Drugs 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C13—SUGAR INDUSTRY
- C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
- C13K11/00—Fructose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB574149A GB668850A (en) | 1949-03-02 | 1949-03-02 | Improved process for producing laevulose-containing solutions for injection purposes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH277825A true CH277825A (de) | 1951-09-15 |
Family
ID=9801776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH277825D CH277825A (de) | 1949-03-02 | 1949-02-05 | Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen. |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH277825A (de) |
| GB (1) | GB668850A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0021953A1 (de) * | 1979-06-15 | 1981-01-07 | Henri Griffon | Stabile wässrige Alloxanlösungen |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990327A (en) * | 1960-07-14 | 1961-06-27 | Synergistics Inc | Composition and method for treating biliary dyskinesia |
-
1949
- 1949-02-05 CH CH277825D patent/CH277825A/de unknown
- 1949-03-02 GB GB574149A patent/GB668850A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0021953A1 (de) * | 1979-06-15 | 1981-01-07 | Henri Griffon | Stabile wässrige Alloxanlösungen |
Also Published As
| Publication number | Publication date |
|---|---|
| GB668850A (en) | 1952-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH290905A (de) | Verfahren zur Herstellung von Halbzellstoff. | |
| CH282375A (de) | Verfahren zur Herstellung von Organohalogensilanen. | |
| CH292033A (de) | Verfahren zur Herstellung von Spinndüsen. | |
| CH277825A (de) | Verfahren zur Herstellung von Lävulose enthaltenden Injektionslösungen. | |
| CH279908A (de) | Verfahren zur Herstellung von Alkylhalogensilanen. | |
| CH298055A (de) | Verfahren zur Herstellung von 1-Phenyl-1-pyridyl-(2')-3-N-pyrolidino-propan-p-amino-salicylat. | |
| CH299374A (de) | Verfahren zur Herstellung von Lösungen von Polymerisaten des Akrylnitrils. | |
| AT171709B (de) | Verfahren zur Herstellung von Oximen | |
| AT172334B (de) | Verfahren zur Herstellung von N-Dialkylaminoalkylphenthiazinen | |
| CH284350A (de) | Verfahren zur Herstellung von Spinndüsen. | |
| CH264601A (de) | Verfahren zur Herstellung von Hydroxylaminsulfat-Lösungen. | |
| CH295660A (de) | Verfahren zur Herstellung von alkylierten Arylmethyl-methylketonen. | |
| CH285128A (de) | Verfahren zur Herstellung von Estern. | |
| AT181692B (de) | Verfahren zur Herstellung von zur Injektion bestimmten Präparaten | |
| CH296339A (de) | Verfahren zur Herstellung von N-(B-Phenyl-äthyl)-äthylenimin. | |
| CH281125A (de) | Verfahren zur Herstellung von Thiosemicarbazid. | |
| AT182823B (de) | Verfahren zur Herstellung wässeriger, zur Injektion geeigneter Lösungen von Chlortetracyclin | |
| AT171176B (de) | Verfahren zur Herstellung von 17α-Methyl-pregnenverbindungen | |
| AT176307B (de) | Verfahren zur Herstellung von 20-Keto-pregnanen | |
| AT169834B (de) | Verfahren zur Herstellung von Pentaenen | |
| AT178203B (de) | Verfahren zur Herstellung von Hartfaserplatten | |
| AT182196B (de) | Verfahren zur Herstellung von Injektionslösungen | |
| AT169805B (de) | Verfahren zur Herstellung von Polysiloxanen | |
| AT167872B (de) | Verfahren zur Herstellung von Injektionslösungen des Chlorhydrates des Methyl-bis-β-Chloräthylamins | |
| AT178163B (de) | Verfahren zur Herstellung von Spasmolytika |